ADVFN ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Coloplast AS (PK)

Coloplast AS (PK) (CLPBY)

6.04
0.27
(4.68%)
Cerrado 05 Julio 3:00PM

Coloplast AS (PK) (CLPBY) Cotización

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Premium

Estadísticas y detalles clave

Último Precio
6.04
( 4.68% )
Postura de Compra
5.43
Postura de Venta
6.57
Volume Operado de la Acción
265,929
5.965 Rango del Día 6.07
5.64 Rango de 52 semanas 10.03
Capitalización de Mercado [m]
Precio Anterior
5.77
Precio de Apertura
5.97
Última hora de negociación
Volumen financiero
US$ 1,599,994
Precio Promedio Ponderado
6.0166
Volumen promedio (3 m)
US$ 381,733
Acciones en circulación
225,166,796
Rendimiento del Dividendo (LTM)
23 (5.68%)
Ratio Precio/Utilidad
40.54
Beneficio por acción (BPA)
9.34
turnover
28.05B
Beneficio neto
2.11B

Acerca de Coloplast AS (PK)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced ... Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; Peristeen Plus, a transanal irrigation system; and Peristeen Light, a low-volume transanal irrigation. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as erectile dysfunction, urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark. Mostrar más

Sector
Healthcare
Industria
Medical Equipment & Supplies
Sitio web
Sede
Humlebæk, Denmark
Fundado
2026
Coloplast AS (PK) is listed in the Healthcare sector of the OTC Markets with ticker CLPBY. The last closing price for Coloplast AS (PK) was US$5.77. Over the last year, Coloplast AS (PK) shares have traded in a share price range of US$ 5.64 to US$ 10.03.

Coloplast AS (PK) currently has 225,166,796 shares in issue. The market capitalisation of Coloplast AS (PK) is US$1.36 billion. Coloplast AS (PK) has a price to earnings ratio (PE ratio) of 40.54.

CLPBY Últimas noticias

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.264.498269896195.786.075.645382315.79187952DR
4-0.01-0.1652892561986.056.145.645462515.84472091DR
12-0.53-8.066971080676.577.045.644915316.18305249DR
26-2.4-28.43601895738.449.15.645660446.87691532DR
52-3.39-35.94909862149.4310.035.644514357.73404952DR
156-6.34-51.21163166412.3814.33965.642419539.16482205DR
260-10.38-63.21559074316.4218.95.641761509.83930619DR

CLPBY - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Coloplast AS (PK)?
El precio actual de las acciones de Coloplast AS (PK) es US$ 6.04
¿Cuántas acciones de Coloplast AS (PK) están en circulación?
Coloplast AS (PK) tiene 225,166,796 acciones en circulación
¿Cuál es la capitalización de mercado de Coloplast AS (PK)?
La capitalización de mercado de Coloplast AS (PK) es USD 1.36B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Coloplast AS (PK)?
Coloplast AS (PK) ha negociado en un rango de US$ 5.64 a US$ 10.03 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Coloplast AS (PK)?
El ratio precio/beneficio de Coloplast AS (PK) es 40.54
¿Cuál es el ratio de efectivo a ventas de Coloplast AS (PK)?
El ratio de efectivo a ventas de Coloplast AS (PK) es 3.04
¿Cuál es la dirección registrada de Coloplast AS (PK)?
La dirección registrada de Coloplast AS (PK) es Holtedam 1-3, Humlebæk, Capital Region of Denmark, 3050
¿Cuál es la dirección del sitio web de Coloplast AS (PK)?
La dirección del sitio web de Coloplast AS (PK) es www.coloplast.com
¿En qué sector industrial opera Coloplast AS (PK)?
Coloplast AS (PK) opera en el sector Medical Equipment & Supplies

CLPBY Operaciones

Más

Operaciones con retraso

Para obtener operaciones en tiempo real, actualice su cuenta

Actualizar a tiempo real
Vexari Vexari 7 minutos hace
Found it below

Much better than a sticky

Thanks Eli
CaptBeer CaptBeer 8 minutos hace
I love how the evidence continues to pile up that ASCVD Risk reduction is not monolithic. It’s NOT “Just” about LDL-c reduction. Despite effective LDL-C lowering, substantial residual ASCVD risk persists. We’re also finding out that reducing triglyceride concentrations alone does not consistently tr
AMRN
Jack_Bolander Jack_Bolander 9 minutos hace
BB - Is a Bot 
BLDP
jammy32 jammy32 10 minutos hace
Five million bonus. Million play salary and Mikah profits he’s already making it. He’s in no hurry. The board is not doing its job. It’s like they have a get out of jail free card when it comes to their fiduciary responsibility. I’d like to see what my lawyers think about a potential lawsu
ELTP
surfer44 surfer44 11 minutos hace
Uranium long term price makes all time high. Bull market intact. AIA Weekly Report 7.4.26

https://youtu.be/DR0H5mI8fIk
TaxHadas TaxHadas 12 minutos hace
does the ceo of AITX realize the """cover is blown"", the gig is up, everyone knows the scam ?
-
investors are dumping bags, closing accounts, writing off the losses , speaking with accountants/lawyers
-
there will NOT be any new investors,
only some ( few) n
AITX
learningcurve2020 learningcurve2020 14 minutos hace
Very informative. The Plll had a very high selection criteria threshold yet they seem to have found plenty of matches? One more powerful survival outcome unmentioned would be the exact tumor location? Unilateral yes but which region? I don’t see that mentioned.

>>4. Defeating the "U
NWBO
AveragePenny AveragePenny 14 minutos hace
Peraso Enters Into Committed Equity Facility of Up to $25 Million

https://www.accessnewswire.com/newsroom/en/computers-technology-and-internet/peraso-enters-into-committed-equity-facility-of-up-to-25-million-1186208

Facility Expected to Provide Access to Additional Wor
PRSO
erg61 erg61 16 minutos hace
As much as I hate to agree, this line of reasoning is spot on. Why have they not approved already? What’s the hold-up? Is corruption involved? If so, how deep does it run? But my questions still remain, Brazen22, why are you here arguing all these posters if you’re not an investor? My only conclusio
NWBO
LOB LOB 17 minutos hace
EliteOGz
1h ago The Invisible Revolution: How Blaqclouds.io Is Killing Clunky Crypto and Embedding DeFi Spendability into the Fabric of Real Life
For years we treated finance like a destination.

You opened the banking app. You logged in. You initiated the transfer. You p
BCDS
bobby1151 bobby1151 19 minutos hace
Who is trip trey????
BIEL
mick mick 20 minutos hace
long wait on cybl , whatzzz wrong here
mick mick 21 minutos hace
thank you, have a great one ? all
Vexari Vexari 21 minutos hace
What happened to the link access

Was fourth down from the top on sticky list
BiotechAce BiotechAce 24 minutos hace
I wonder if Tony opened a fireworks stand in the name of Apple Rush? He said the profits would be huge. Very helpful to the shareholders. He was probably giving away a free Apple Rush fruit drink with any purchase over $20. Soon we will see it all on the financials.
APRU
JamesF1 JamesF1 27 minutos hace
Jammy32,  I don’t think Nasrat should be fired. I do agree that he is making out very well as CEO of ELTP.   Keep in mind that Nasrat is the largest shareholder of ELTP.  He wins big if ELTP shareholders win.  
ELTP
rogers711 rogers711 27 minutos hace
Yes another buying opportunity to wait another year in my opinion… 
RDGL
peanutz peanutz 29 minutos hace
I'm not going to put to much into the 8th date . Watching for the first "set" of pr's for direction and their plans for the near future . Don't want to get disappointed if they miss the 8th.
TWOH
PhantomEnchanter891 PhantomEnchanter891 30 minutos hace
Seems to always be wrong. November to remember. February to be our year.

Now, it will be 1 to 18 months? Guess that about settles it!

I can't believe the bride will be left at the altar for more than 3 months. Pulte and even Bessent spoke over 6 months ago and were tal
FNMA
SamuraiAdventurer88 SamuraiAdventurer88 31 minutos hace
Still peanut volume and not consistent.
HHSE
The-Shadow The-Shadow 33 minutos hace
> **DFMI/DFI (Panik’s entity) could not legally claim ownership of SVF/Softvideo because TMM/TMMI never assigned that IP to any third party.

> ISI only received a development license to build fractal math inside TMM’s existing SVF framework.

> Therefore, DFMI’s late
TMMI
iHub News iHub News 36 minutos hace
Brokerages Accelerate Rollout of AI Trading Tools as Automated Investing ExpandsJuly 5, 2026 10:06 AM
IH Market News
HOOD
iHub News iHub News 36 minutos hace
Brokerages Accelerate Rollout of AI Trading Tools as Automated Investing ExpandsJuly 5, 2026 10:06 AM
IH Market News
IBKR
iHub News iHub News 36 minutos hace
Brokerages Accelerate Rollout of AI Trading Tools as Automated Investing ExpandsJuly 5, 2026 10:06 AM
IH Market News
TW